Source: Virtual Congress 2020 – Risk factors for chronic lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Bleecker (Tucson, AZ, United States of America), K. Murphy (Boys Town, NE, United States of America), H. Gandhi (Wilmington, DE, United States of America), I. Gilbert (Wilmington, DE, United States of America), J. Zein (Cleveland, OH, United States of America), J. Reibman (New York, NY, United States of America), G. Chupp (New Haven, CT, United States of America). Natural history of disease burden for US patients with asthma vs asthma and COPD. 1397

Member's Comments

No comment yet.

Related content which might interest you: COPD patients with asthma, characteristics and risk of exacerbations Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Management of patients with asthma or COPD and cardiovascular disease: risks versus benefits Source: Eur Respir Monogr 2020; 88: 66-81 Year: 2020 Sexuality in patients with asthma and/or COPD Source: Eur Respir J 2003; 22: Suppl. 45, 54s Year: 2003 Assessment of a disease management program for patients with asthma or COPD Source: Eur Respir J 2005; 26: Suppl. 49, 19s Year: 2005 The course of disease of patients who died from asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 217s Year: 2003 The relation of comorbidities with the exacerbation severity in patients with COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Are COPD exacerbations associated with the severity of the disease? Source: Eur Respir J 2005; 26: Suppl. 49, 300s Year: 2005 Effect of cumulative smoking history on disease burden and multimorbidity in adult-onset asthma Source: International Congress 2018 – Asthma management Year: 2018 Impact of comorbidities on chronic obstructive pulmonary disease (COPD) exacerbations in Singapore Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Sexuality in patients with asthma and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 273s Year: 2005 Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema Source: Eur Respir J 2001; 17: 596-603 Year: 2001 Physiological impairments and exacerbation risk in COPD patients with less symptom and no frequent exacerbation history. Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 Lack of effect of acute exacerbations on disease progression in ex-smoker COPD patients Source: Annual Congress 2010 - Distortions of the respiratory system in the lung function Year: 2010 Anxiety and low health status are predictors of exacerbations in patients with obstructive pulmonary disease Source: Annual Congress 2006 - Muscles, training and rehabilitation Year: 2006 The prevalence of chronic obstructive pulmonary disease (COPD) in individuals with diabetes, hypertension, asthma, or mood/anxiety disorders: A Canadian population study Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities Year: 2012 Complexity in chronic asthma and COPD: implications for risk assessment, disease progression and control Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008 The prevalences of asthma and atopy in bronchiectasis patients Source: Eur Respir J 2006; 28: Suppl. 50, 322s Year: 2006 Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort Source: Annual Congress 2013 –The best posters in chronic care Year: 2013 Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021 Acute exacerbations of COPD: The influence of comorbidities and chronic medication on mortality and exacerbation rate Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015